Search Ontology:
ChEBI

alpha-L-Fucp-(1->2)-alpha-D-Galp-(1->3)-D-GlcpNAc

Term ID
CHEBI:146946
Synonyms
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-alpha-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-gluco-hexopyranose
  • 6-deoxy-alpha-L-galactopyranosyl-(1->2)-alpha-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-glucopyranose
  • alpha-L-fucopyranosyl-(1->2)-alpha-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-glucopyranose
  • Fuc(a1-2)Gal(a1-3)GlcNAc
  • N-[(3R,4R,5S,6R)-4-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of α-L-fucopyranosyl, α-D-galactopyranosyl and 2-acetamido-D-glucopyranose residues joined in sequence by (1→2) and (1→3) glycosidic linkages.
References
  • glygen:G09223OK
  • glytoucan:G09223OK
  • kegg.glycan:G08224
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-alpha-D-Galp-(1->3)-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->2)-alpha-D-Galp-(1->3)-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-alpha-D-Galp-(1->3)-D-GlcpNAc
Phenotype affecting alpha-L-Fucp-(1->2)-alpha-D-Galp-(1->3)-D-GlcpNAc
Human Disease Model